We would love to hear your thoughts about our site and services, please take our survey here.
Thanks for link Trojan.
RM looked perhaps a little less assured this morning than hitherto - but the message remains the same - which in my words is effectively - we keep going forward. At this sp level, with sufficient funds for the next 12 months, in my opinion they have time to find partners/trials.
As a LTH and having been here before many years ago (pre.AstraZeneca), the sp could rub along the bottom pence range quite easily. So, I really hope that RM makes an effort tomorrow with his presentation. For all our sakes - not just mine. GLA
What a surprise to read the latest announcement as I was eating my porridge this morning. I agree Truro Trader it reads surprisingly well and they only want another £10m to be a part of the party.
I like that the lines can be setup close to the site - presumably it's a messy process which would find difficulty in getting planning permission over here ? If only the first location wasn't in Albania where the corruption is even worse that Kosovo. Will Chris Gilbert be taking an active part greasing the politicians ?
On paper, it sounds so promising - but probably not to all those Fox shareholders like me backing a miserable investment all these years. Perhaps, for once, it will all turn out right for us ?
Well, back to my porridge. Good luck all.
Scharnhorst - you sum it up nicely.
- We didn't get any wellness figures - lots of nice words though.
- Regarding the background problems with Nell Health - we learned nothing other than Penny took quite a deep breath when the question was raised (negative body language ?) but she skimmed past it.
- We learned they save £25,000 per month by closing the Manchester lab - but it seems MHC happy to outsource it all to Acculabs - is that a wise business move ?
- the team is only 12 persons which must limit potential and explains why the 'wellness' products were delayed in my opinion - but she said they intend to expand numbers.
- and Adam (Chairman) when asked about shareprice being exactly the same (1.75p) as when they started in their new guise 2020 and yet now having turned a very useful profit, was rather sanguine with his answer - fault of AIM generally.
I don't want to be accused of being negative because the mood-music from Penny was really great - a lot rides on that one person's shoulders. If you're happy with that, then the current sp could eventually come to be seen as an absolute bargain.
GLA
jamrock & cuvio - there has clearly been a significant problem getting these 'wellness' products out.
Other contributors to this BB regularly pointed out the delay in getting them out - last year, the inference was they'd be out in the New Year and I don't believe for one moment the delay was because Management had other things to do. I can't recall in recent years of shares I have followed, whether owned or thinking about investing, where such a critical performance target was missed so completely that the Nell Health investors will miss out on £1 million MHC shares. What lies behind this ? Some of the original Nell Health are still around but is this going to cause them and MHC management problems ?
In other things, if we can be told that July was record-breaking, what about August's trading - the figures will be known but we're not being told despite it covering the main holiday travel period and Covid sales. Personally, I don't want to read more about future 'new' products, as good as I recognise they have to urgently build sales strength away from Covid, when we haven't had information on their existing 'new' ones.
I've received marketing emails on all of the current products - they're informative but I wouldn't say they 'sell' the products to me - there's no marketing thrust. There was a 'dynamism' this time last year, I'm concerned that I'm seeing a more pedestrian performance. Anyway, as I've already said I'm staying as a shareholder, but I am frustrated - I shall try to formulate one or two pertinent questions including about Nell Health and I recommend other shareholders consider doing the same.
GLA
Sorry correction:
3. Now we learn that Nell Health will not be receiving £1 million in shares as they have failed to meet performance targets.
I'm disappointed by the results - they're simply not good enough and the sp reflects that I regret to say. No amount of gilding the lilly will change things.
1. We have all known on this BB that the delivery of the 'Wellness' products is way beyond what was projected.
2. We have worked out for ourselves that sales have not yet happened - by the simple fact there are no TrustPilot reviews.
3. Now we learn that Nell Health will not be receiving £1 in shares as they have failed to meet performance targets. Those targets were sales of between £800,000 and £1,600.000 in 2022. I believe that is 12 months from takeover which was end June 2021.
I am still a holder of MHC shares so not in any way deramping the shares, but I had hoped in July that by today we would have seen a decent uplift of the sp to around 3.5p. But based on today's announcements, I can't see that happening until we see some meaningful sales figures from the 'Wellness' products. GLA
RNS tomorrow or Friday perhaps ?
Brand - thanks for your updates today which are getting lost in the silliness of others.
I was particularly interested in the piece from University of Southampton's Summer magazine on Dr. Sarah Puddicombe who helped on the early development of SNG. Written apparently for the Summer 2022 magazine it reads very positive on Interferon Beta - I bet a conversation with her would get us to understand just what are the true benefits of the treatment going forward. Thanks again Brand.
GLA.
You're right Discoman1 - this explains to me why they would appear to be moving towards a multi launch worldwide. There's clearly a beneficial response to Eroxon which has been confirmed by Coopers who are going supply the EU/UK market. Presumably with little active ingredients now the chemical has been stripped out, copies are bound to happen. But if the brand is promoted in one big hit as it were and is not expensive, buyers will want to stick with Eroxon.
I wish I could be more patient after all these years but even so, the end-game is now making far more sense as we get closer to it and consequently looking far more promising financially. GLA
billywild - this forum is far more active than for other shares - some of the detail is extremely insightful but a lot isn't frankly. I've been a stockmarket investor for 50 years and made mistakes early on when I started out. But over the years I realised one needs to be more patient and try not to watch prices on a daily basis. Now is not the time for me to give you advice - I completely understand - you just want to see Synairgen recover its price.
Try to be patient.
Try not to worry.
Ghia gave a very considered answer to you - he concluded that if you can stick it out, there's a good likelihood you'll be OK. Despite my experience, I too got carried away and my loss is about 4 times yours but your worry is greater than mine as I don't have mortgage worries like you. I think this is going to take much more time - try to accept that and I'm hoping we'll be both be OK.
Good luck Billy
Kdonky1000 - thanks for sharing your response from Optimum and for your efforts trying to get more info from FUM.
As a LTH it’s been quite a long journey- the sp has been all over the place and we’ve had some placings too over the years. Lombard Odier has been supportive but they have done well out of the stock selling it down at very good prices and buying it back at the 7p placing when the Board’s mismanagement nearly lost the company. I have made some money myself selling some of my holding at last year’s peak 81p when the CE mark announcement was given. But I have since added back thinking by now we’d have been selling the product. It’s the lack of selling that has held this share back - the market is clearly sceptical that eroxon actually exists. Even I’m sceptical to be honest even though I’m heavily invested.
You’d be forgiven in thinking that this whole enterprise is a ‘fraud’ - it’s only reason for existence is to pay Barder’s wages. But, I’m now of the opinion that they want to have all markets coming to the fore at the same time - which means waiting for the FDA approval before releasing any product.
If that view is correct, then I feel the sp will at best tread water for the rest of the year. Good luck all LTHs.
A late interesting trade this afternoon:
06-Sep-22 14:45:09 2.00 1,000,000 Unknown* 1.90 2.10 20.00k
"Guess when results are out they will be buying more as they were all nibbling at much bigger prices earlier in the year"
I'd like to think so too davey50. So, decided to add to my holding today at .06p ahead of the audited results supposed to be later this month. I take comfort from the recent trading update where there announced they weren't expecting the accounts to be a problem. With the sp at this low level and the Directors/PDMR buying and converting options close to or at 1p and even the Chairman having paid around 1.24p earlier this year, these are serious percentage differences compared with todays market.
Hoping this will prove a good opportunity. GLA
The audit is very largely complete, no issues have been raised, and the audited results are expected to be announced in the middle of September 2022.